These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37311280)

  • 1. Cardiovascular disease treatment using traditional Chinese medicineļ¼šMitochondria as the Achilles' heel.
    Gao J; Hou T
    Biomed Pharmacother; 2023 Aug; 164():114999. PubMed ID: 37311280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms.
    Dai J; Qiu L; Lu Y; Li M
    Front Endocrinol (Lausanne); 2024; 15():1366285. PubMed ID: 39403576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of Traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway.
    Li B; Nasser MI; Masood M; Adlat S; Huang Y; Yang B; Luo C; Jiang N
    Biomed Pharmacother; 2020 Jun; 126():110074. PubMed ID: 32163746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitochondrial dysfunction induced by excessive ROS/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention].
    Zhang C; Liu J; Pan H; Yang X; Bian K
    Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(17):2423-8. PubMed ID: 22121816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management.
    Wang J; Zou J; Shi Y; Zeng N; Guo D; Wang H; Zhao C; Luan F; Zhang X; Sun J
    Phytomedicine; 2024 Jun; 128():155472. PubMed ID: 38461630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action.
    Li L; Ran Y; Wen J; Lu Y; Liu S; Li H; Cheng M
    Curr Pharm Biotechnol; 2024; 25(17):2186-2199. PubMed ID: 38347793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases.
    Liu J; Wei X; Wang T; Zhang M; Gao Y; Cheng Y; Chi L
    Front Pharmacol; 2024; 15():1372766. PubMed ID: 38469405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases.
    Panda P; Verma HK; Lakkakula S; Merchant N; Kadir F; Rahman S; Jeffree MS; Lakkakula BVKS; Rao PV
    Oxid Med Cell Longev; 2022; 2022():9154295. PubMed ID: 35783193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases.
    Shaito A; Aramouni K; Assaf R; Parenti A; Orekhov A; Yazbi AE; Pintus G; Eid AH
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):105. PubMed ID: 35345337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between Mitochondrial Dysfunction, Cardiovascular Diseases, and Traditional Chinese Medicine.
    Zhu L; Chen Z; Han K; Zhao Y; Li Y; Li D; Wang X; Li X; Sun S; Lin F; Zhao G
    Evid Based Complement Alternat Med; 2020; 2020():2902136. PubMed ID: 33101442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease.
    Li B; Xu X; Wang X; Yu H; Li X; Tao W; Wang Y; Yang L
    Int J Mol Sci; 2012 Oct; 13(10):13501-20. PubMed ID: 23202964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases.
    Beg MA; Huang M; Vick L; Rao KNS; Zhang J; Chen Y
    Trends Pharmacol Sci; 2024 Apr; 45(4):290-303. PubMed ID: 38458847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases.
    Victor VM; Rocha M
    Curr Pharm Des; 2007; 13(8):845-63. PubMed ID: 17430185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease.
    Chen K; Keaney JF
    Curr Atheroscler Rep; 2012 Oct; 14(5):476-83. PubMed ID: 22956414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics.
    Rocha M; Apostolova N; Hernandez-Mijares A; Herance R; Victor VM
    Curr Med Chem; 2010; 17(32):3827-41. PubMed ID: 20858217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases.
    Kirkman DL; Robinson AT; Rossman MJ; Seals DR; Edwards DG
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H2080-H2100. PubMed ID: 33834868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mitochondrial dysfunction in cardiovascular disease: a brief review.
    Chistiakov DA; Shkurat TP; Melnichenko AA; Grechko AV; Orekhov AN
    Ann Med; 2018 Mar; 50(2):121-127. PubMed ID: 29237304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of mitochondria as target of traditional Chinese medicines in treatment of heart failure].
    Huang K; Gao JM; He S; Zhu Y
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(9):2082-2090. PubMed ID: 32495557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mitochondrial Approach to Cardiovascular Risk and Disease.
    Veloso CD; Belew GD; Ferreira LL; Grilo LF; Jones JG; Portincasa P; SardĆ£o VA; Oliveira PJ
    Curr Pharm Des; 2019; 25(29):3175-3194. PubMed ID: 31470786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases.
    He F; Zuo L
    Int J Mol Sci; 2015 Nov; 16(11):27770-80. PubMed ID: 26610475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.